Search research articles
Contact Us
Filters
Showing results (11-20 of 13) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 13 results.
The Journal of Pharmacology and Experimental Therapeutics
|
February 24, 2004
S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: II. Actions in rodent, primate, and cellular models of antiparkinsonian activity in comparison to ropinirole
Mark J Millan, Benjamin Di Cara, Michael Hill, et al.
BMC Bioinformatics
|
September 24, 2015
Group-based variant calling leveraging next-generation supercomputing for large-scale whole-genome sequencing studies
Kristopher A Standish, Tristan M Carland, Glenn K Lockwood, et al.
Neuro-Oncology Advances
|
August 22, 2025
First-in-human study of an EGFRvIII x CD3 T cell bispecific antibody in the treatment of newly diagnosed glioblastoma
James R Whittle, Maria Vieito, Kristoffer Rohrberg, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 13) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 13 results.
The Journal of Pharmacology and Experimental Therapeutics
|
February 24, 2004
S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: II. Actions in rodent, primate, and cellular models of antiparkinsonian activity in comparison to ropinirole
Mark J Millan, Benjamin Di Cara, Michael Hill, et al.
BMC Bioinformatics
|
September 24, 2015
Group-based variant calling leveraging next-generation supercomputing for large-scale whole-genome sequencing studies
Kristopher A Standish, Tristan M Carland, Glenn K Lockwood, et al.
Neuro-Oncology Advances
|
August 22, 2025
First-in-human study of an EGFRvIII x CD3 T cell bispecific antibody in the treatment of newly diagnosed glioblastoma
James R Whittle, Maria Vieito, Kristoffer Rohrberg, et al.
Page
of 2